Transition Therapeutics Inc. (TTH.TO, TTHI) posted a first quarter net loss and comprehensive loss of C$5.6 million or C$0.24 per share, compared to a loss of C$5.03 million or C$0.22 per share in the previous year quarter.
Revenue for the quarter were C$0.30 million, compared to nil last year. Research and development expenses decreased to C$3.07 million, compared to C$3.73 million in the previous year quarter.
For comments and feedback: editorial@rttnews.com